The Biotech Growth Trust PLC (“the Company”)
Compliance with Market Abuse Regulation
29 April 2022
The Company confirms that:
a) all inside information which the Directors and Company may
have had has been notified to a Regulated Information Service (“RIS”);
b) the Company’s net asset value per share is calculated and
announced through a RIS on a daily basis;
c) the Company has no reason to believe that there will be any
material difference between the net asset value per share as at close of
business on Thursday 31 March 2022, which was announced on Friday, 1 April
2022, and the financial information to be published in the announcement of its
results for the year ended 31 March 2022.
The Company is, therefore, not prohibited from dealing in its own securities
during the closed period, as defined by the UK Market Abuse Regulation, which
will end on the date of the publication of its results for the year ended 31
March 2022, expected to be on or after Wednesday, 1 June 2022.
-ENDS-
For further information please contact:
Katherine Manson Frostrow Capital LLP - 020 3 709 8734
Copyright (c) 2022 PR Newswire Association,LLC. All Rights Reserved